Trial Profile
Evaluation of peri-operative dopaminergic replacement with with rotigotine transdermal patch in patients with Parkinson's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2016
Price :
$35
*
At a glance
- Drugs Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 22 Sep 2016 New trial record